BTCP maleatePotent dopamine uptake inhibitor CAS# 207455-25-2 |
- ARL 67156 trisodium salt
Catalog No.:BCC7004
CAS No.:1021868-83-6
- ML-7 hydrochloride
Catalog No.:BCC1770
CAS No.:110448-33-4
- Sodium Orthovanadate
Catalog No.:BCC3856
CAS No.:13721-39-6
- Tipifarnib (Zarnestra)
Catalog No.:BCC2253
CAS No.:192185-72-1
- Ciclopirox ethanolamine
Catalog No.:BCC4372
CAS No.:41621-49-2
- Omecamtiv mecarbil
Catalog No.:BCC3710
CAS No.:873697-71-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 207455-25-2 | SDF | Download SDF |
PubChem ID | 10251290 | Appearance | Powder |
Formula | C23H29NO4S | M.Wt | 415.55 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO | ||
Chemical Name | 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine;(Z)-but-2-enedioic acid | ||
SMILES | C1CCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCCC4.C(=CC(=O)O)C(=O)O | ||
Standard InChIKey | AMTYJSWZECGJOO-BTJKTKAUSA-N | ||
Standard InChI | InChI=1S/C19H25NS.C4H4O4/c1-5-11-19(12-6-1,20-13-7-2-8-14-20)18-15-16-9-3-4-10-17(16)21-18;5-3(6)1-2-4(7)8/h3-4,9-10,15H,1-2,5-8,11-14H2;1-2H,(H,5,6)(H,7,8)/b;2-1- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | A potent dopamine re-uptake inhibitor with a behavioral profile different from that of PCP and similar to that of cocaine. |
BTCP maleate Dilution Calculator
BTCP maleate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4064 mL | 12.0322 mL | 24.0645 mL | 48.129 mL | 60.1612 mL |
5 mM | 0.4813 mL | 2.4064 mL | 4.8129 mL | 9.6258 mL | 12.0322 mL |
10 mM | 0.2406 mL | 1.2032 mL | 2.4064 mL | 4.8129 mL | 6.0161 mL |
50 mM | 0.0481 mL | 0.2406 mL | 0.4813 mL | 0.9626 mL | 1.2032 mL |
100 mM | 0.0241 mL | 0.1203 mL | 0.2406 mL | 0.4813 mL | 0.6016 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- L-693,403 maleate
Catalog No.:BCC5657
CAS No.:207455-21-8
- N-MPPP Hydrochloride
Catalog No.:BCC5672
CAS No.:207452-97-9
- Arteannuin N
Catalog No.:BCN4907
CAS No.:207446-92-2
- Arteannuin M
Catalog No.:BCN4906
CAS No.:207446-90-0
- Arteannuin L
Catalog No.:BCN4905
CAS No.:207446-89-7
- MR 16728 hydrochloride
Catalog No.:BCC6684
CAS No.:207403-36-9
- 3-Bromocytisine
Catalog No.:BCC7705
CAS No.:207390-14-5
- Dihydrosinapylalcohol
Catalog No.:BCN6542
CAS No.:20736-25-8
- Saikosaponin A
Catalog No.:BCN1086
CAS No.:20736-09-8
- Saikosaponin C
Catalog No.:BCN1087
CAS No.:20736-08-7
- 1,8-Bis(dimethylamino)naphtalene
Catalog No.:BCC8429
CAS No.:20734-58-1
- Methyl sinapate
Catalog No.:BCN4675
CAS No.:20733-94-2
- (±)-1-(1,2-Diphenylethyl)piperidine maleate
Catalog No.:BCC6619
CAS No.:207461-99-2
- Pirlindole mesylate
Catalog No.:BCC6764
CAS No.:207572-66-5
- iso-PPADS tetrasodium salt
Catalog No.:BCC6749
CAS No.:207572-67-6
- SB 203186 hydrochloride
Catalog No.:BCC5673
CAS No.:207572-69-8
- H-Phe(4-NO2)-OH.H2O
Catalog No.:BCC3273
CAS No.:207591-86-4
- TPT-260 Dihydrochloride
Catalog No.:BCC5172
CAS No.:2076-91-7
- HS 014
Catalog No.:BCC5819
CAS No.:207678-81-7
- 5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)
Catalog No.:BCC4583
CAS No.:207679-81-0
- 1,7-Bis(4-hydroxyphenyl)-3-hydroxy-1,3-heptadien-5-one
Catalog No.:BCN6470
CAS No.:207792-17-4
- Propofol
Catalog No.:BCC9130
CAS No.:2078-54-8
- Isobavachalcone
Catalog No.:BCN5415
CAS No.:20784-50-3
- 4'-O-Methylbroussochalcone B
Catalog No.:BCN4908
CAS No.:20784-60-5
Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist properties.[Pubmed:1397045]
Eur J Pharmacol. 1992 Aug 14;219(1):169-72.
The effects of the phencyclidine derivative, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine (BTCP), on the electrical activity of noradrenaline (NA) neurons of the locus coeruleus (LC) were studied in halothane-anesthetized rats. Systemic administration of BTCP potently inhibited LC neurons (ID50 of 1.1 +/- 0.1 mg/kg i.v.). This effect was mimicked by local microejection of BTCP into the LC. Both the systemic and local effects of BTCP were blocked by alpha 2-adrenoceptor antagonists and prevented by prior depletion of catecholamines with reserpine. These and other data suggest that BTCP behaves as a potent indirect NA agonist (i.e. via NA re-uptake and/or release systems).
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.[Pubmed:2674416]
J Pharmacol Exp Ther. 1989 Sep;250(3):1019-27.
Phencyclidine (PCP) inhibits dopamine (DA) uptake and acts as a noncompetitive N-methyl-D-aspartate antagonist by binding to PCP receptors. The PCP analog N-[1-(2-benzo(b)thiophenyl) cyclohexyl]piperidine (BTCP, GK13) is a potent DA uptake inhibitor, but has low affinity for PCP receptors. The behavioral effects of BTCP were compared with those of PCP, ketamine, MK-801 and cocaine. In mice, BTCP, like cocaine, produced locomotion, sniffing and gnawing; haloperidol blocked these effects. PCP, ketamine and MK-801 produced locomotion, sniffing, swaying and falling. PCP, ketamine and MK-801 produced generalization in rats discriminating either cocaine, PCP or MK-801 from saline. Like cocaine, BTCP produced generalization in cocaine-discriminating rats only; haloperidol partially antagonized this effect. In pigeons, PCP-like catalepsy was produced by ketamine and MK-801, but not by BTCP. N-methyl-D-aspartate-induced convulsions in mice were antagonized by PCP, ketamine and MK-801, but not by BTCP or cocaine. Thus, BTCP shared only cocaine-like behavioral effects with PCP, ketamine and MK-801. A DA antagonist reduced the effects of BTCP. Therefore, the cocaine-like behavioral effects of BTCP may be mediated primarily by DA uptake mechanisms. However, PCP receptors, but not DA uptake mechanisms, may mediate the cocaine-like behavioral effects of PCP, ketamine and MK-801, because their order of potency in producing these effects (MK-801 greater than PCP greater than ketamine) is consistent with their potency order at PCP receptors, but not at DA uptake sites.
[3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex.[Pubmed:3384005]
Eur J Pharmacol. 1988 Apr 13;148(3):427-36.
A benzothiophenyl group instead of a phenyl ring on phencyclidine (PCP) yields a molecule N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine (BTCP), which is one of the more potent known dopamine (DA) uptake inhibitors (IC50 = 7 nM). This compound also has low affinity for the PCP receptor (K0.5 = 6 microM). The sodium-dependent [3H]BTCP binding to rat striatal membranes was investigated. [3H]BTCP bound to two different sites: one with very high affinity (Kd1 = 0.9 nM, Bmax1 = 3.5 pmol/mg protein) which paralleled the distribution of dopaminergic nerve endings and a second with lower affinity (Kd2 = 20 nM, Bmax2 = 7.5 pmol/mg protein). There was a good correlation between the abilities of drugs specific for the DA uptake complex and of PCP analogs to inhibit high affinity [3H]BTCP binding and [3H]DA synaptosomal uptake. This study also demonstrated that PCP interacts with the DA uptake site since it is a competitive inhibitor of high affinity [3H]BTCP binding. This site, however, is not the PCP receptor, which has a different pharmacological selectivity.